INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,431,000 | -26.3% | 375,399 | +3.5% | 0.07% | -1.4% |
| Q1 2022 | $26,361,000 | -76.5% | 362,750 | -61.7% | 0.07% | -72.5% |
| Q4 2021 | $111,954,000 | -20.6% | 946,834 | -9.9% | 0.26% | -24.3% |
| Q3 2021 | $140,965,000 | -2.3% | 1,050,799 | +17.9% | 0.34% | -3.2% |
| Q2 2021 | $144,245,000 | +164.7% | 890,900 | +31.2% | 0.35% | +150.4% |
| Q1 2021 | $54,504,000 | +1438.4% | 679,141 | +155.9% | 0.14% | +1058.3% |
| Q3 2019 | $3,543,000 | -23.6% | 265,382 | -6.3% | 0.01% | -20.0% |
| Q2 2019 | $4,638,000 | -24.4% | 283,286 | -21.1% | 0.02% | -25.0% |
| Q1 2019 | $6,133,000 | +79.5% | 359,028 | +43.5% | 0.02% | +66.7% |
| Q4 2018 | $3,416,000 | -27.7% | 250,203 | +51.6% | 0.01% | -7.7% |
| Q3 2018 | $4,725,000 | – | 165,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |